Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.01
Delayed Data
As of Dec 02
 +0.05 / +2.55%
Today’s Change
1.81
Today|||52-Week Range
5.30
-58.47%
Year-to-Date
3 Small-Cap Biotech Stocks That Could Double in 2017
Dec 02 / MotleyFool.com - Paid Partner Content
Penny Stocks: 2 to Buy, 2 to Avoid
Nov 20 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close1.96
Today’s open1.96
Day’s range1.96 - 2.04
Volume727,954
Average volume (3 months)1,690,706
Market cap$319.9M
Dividend yield--
Data as of 4:00pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,054.47%
P/E ratioNM
Price/Sales21.65
Price/Book2.25

Competitors

 Today’s
change
Today’s
% change
BTXBioTime Inc-0.06-1.85%
EDGEEdge Therapeutics In...-0.07-0.61%
ONVOOrganovo Holdings In...+0.05+1.73%
NDRMNeuroderm Ltd0.000.00%
Data as of 4:00pm ET, 12/02/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$36.4M
Annual profit (last year)$46.0K
Net profit margin0.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs